Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

P3 Health Partners (PIII) Total Non-Current Liabilities (2020 - 2025)

Historic Total Non-Current Liabilities for P3 Health Partners (PIII) over the last 6 years, with Q3 2025 value amounting to $657.1 million.

  • P3 Health Partners' Total Non-Current Liabilities rose 1953.85% to $657.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $657.1 million, marking a year-over-year increase of 1953.85%. This contributed to the annual value of $623.6 million for FY2024, which is 4762.83% up from last year.
  • Per P3 Health Partners' latest filing, its Total Non-Current Liabilities stood at $657.1 million for Q3 2025, which was up 1953.85% from $622.2 million recorded in Q2 2025.
  • Over the past 5 years, P3 Health Partners' Total Non-Current Liabilities peaked at $657.1 million during Q3 2025, and registered a low of $175612.0 during Q1 2021.
  • In the last 5 years, P3 Health Partners' Total Non-Current Liabilities had a median value of $391.2 million in 2023 and averaged $336.3 million.
  • Its Total Non-Current Liabilities has fluctuated over the past 5 years, first skyrocketed by 6091476.61% in 2022, then surged by 1893.06% in 2024.
  • Quarter analysis of 5 years shows P3 Health Partners' Total Non-Current Liabilities stood at $390352.0 in 2021, then surged by 28655.58% to $112.2 million in 2022, then surged by 276.31% to $422.4 million in 2023, then soared by 47.63% to $623.6 million in 2024, then grew by 5.38% to $657.1 million in 2025.
  • Its last three reported values are $657.1 million in Q3 2025, $622.2 million for Q2 2025, and $631.1 million during Q1 2025.